Myrtle Greenwood, Harry Lewis, Georgia Roberts, Imogen Taylor
Publications
Assessing the definition and outcomes of innovative drugs by Health Technology Assessment bodies in England, France, and Italy (Q1 2023)
Published on 1 December 2023
Virtual modified Delphi research into current and future management approaches of multiple myeloma in Sweden
Georgia Roberts, Andrew Mumford, Joanne Mumford
Published on 10 December 2020
Reasons for a negative Pharmaceutical Benefits Advisory Committee (PBAC) review in rare diseases in Australia: A comprehensive analysis
Oliver Darlington, Sarah Jane Lyttle, Andrew Mumford, Adelaide Shaw-Maguire
Published on 10 September 2024
Evaluation of the UK Innovative Licensing and Access Pathway
David Ringger, Adelaide Shaw-Maguire, Imogen Taylor
Published on 1 December 2022
The global early access programme landscape and its application to cell and gene therapies
William Irvin, Andrew Mumford, Georgia Roberts, Laura Sopeña Alvarez
Published on 10 May 2021
Cost-effectiveness analysis of paclitaxel micellar for treatment of first relapse platinum sensitive ovarian cancer
Tom Edmonds, Bethany English, Clive Witcher, Andrew Mumford
Published on 1 December 2022
Events & conferences
We attend a number of major conferences and would love to meet you at the events listed below:
WODC Barcelona 2024
22nd to 25th October 2024
ISPOR Barcelona 2024
17th to 20th November 2024
Talks & webinars
As market access and HEOR experts, we are regularly asked to talk at industry events. We’d love to see you in our audience at the following events: